Darryl joined CellCentric in August 2026.

Darryl brings over a decade of healthcare and pharmaceutical industry experience, with a primary focus on clinical strategy, medical communication, and field medical affairs in oncology and hematology. Darryl has extensive expertise in key opinion leader engagement, cross-functional launch strategy, and clinical trial support for novel oncology assets, particularly bispecific T-cell engagers and targeted therapies in multiple myeloma.

Prior to joining CellCentric, Darryl served as Associate Director of Medical Affairs in Hematology at Regeneron. Before that, he spent several years as a Medical Science Liaison at Johnson & Johnson, driving medical execution and scientific exchange for their multiple myeloma pipeline while also earning the “Living the Mission” award twice for demonstrating outstanding medical affairs excellence, learning agility, and impactful peer leadership.

Darryl holds a Doctor of Pharmacy (PharmD) degree from the University of Colorado.